Cargando…

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function

BACKGROUND: Type 2 diabetes mellitus increases the risk of cardiovascular disease including myocardial infarction (MI). Inflammation and apoptosis have been implicated in the pathophysiology of MI. In the present study, the effects of astragaloside IV (AS-IV) on MI in diabetic mice were evaluated. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Chuang, Zeng, Guangwei, Wang, Tingting, Ren, He, An, Huixian, Lian, Cheng, Liu, Jing, Guo, Li, Li, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358605/ https://www.ncbi.nlm.nih.gov/pubmed/34395418 http://dx.doi.org/10.3389/fcell.2021.671255

Ejemplares similares

CD73(+) Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis
por: Li, Qiong, et al.
Publicado: (2021)

Isolevuglandins Scavenger Ameliorates Myocardial Ischemic Injury by Suppressing Oxidative Stress, Apoptosis, and Inflammation
por: Guo, Junjie, et al.
Publicado: (2022)

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC‐1α to reduce apoptosis in vitro and in vivo
por: Xie, Mingxia, et al.
Publicado: (2023)

Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2017)

Role of PDGF-A/B Ligands in Cardiac Repair After Myocardial Infarction
por: Kalra, Kunal, et al.
Publicado: (2021)

The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy
por: Li, Ziyu, et al.
Publicado: (2022)

MiR-144-3p Enhances Cardiac Fibrosis After Myocardial Infarction by Targeting PTEN
por: Yuan, Xiaolong, et al.
Publicado: (2019)

Correlation between Glycated Haemoglobin Level, Cardiac Function, and Prognosis in Patients with Diabetes Mellitus Combined with Myocardial Infarction
por: Zeng, Guangwei, et al.
Publicado: (2022)

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
por: Luo, Li-Fei, et al.
Publicado: (2021)

Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites
por: Du, Xu-Qin, et al.
Publicado: (2022)

Differential Effects of Reperfusion on Cardiac Mitochondrial Subpopulations in a Preclinical Porcine Model of Acute Myocardial Infarction
por: Chandra Shekar, Kadambari, et al.
Publicado: (2022)

Angiogenic function of astragaloside IV in rats with myocardial infarction occurs via the PKD1-HDAC5-VEGF pathway
por: Yang, Lei, et al.
Publicado: (2019)

The Novel Non-coding Transcriptional Regulator Gm18840 Drives Cardiomyocyte Apoptosis in Myocardial Infarction Post Ischemia/Reperfusion
por: Luo, Changjun, et al.
Publicado: (2021)

Cardiac Mesenchymal Cells Cultured at Physiologic Oxygen Tension Have Superior Therapeutic Efficacy in Heart Failure Caused by Myocardial Infarction
por: Bolli, Robi A. R., et al.
Publicado: (2021)

Cardiac Derived CD51-Positive Mesenchymal Stem Cells Enhance the Cardiac Repair Through SCF-Mediated Angiogenesis in Mice With Myocardial Infarction
por: Xie, Dong Mei, et al.
Publicado: (2021)

Circular RNA POSTN Promotes Myocardial Infarction-Induced Myocardial Injury and Cardiac Remodeling by Regulating miR-96-5p/BNIP3 Axis
por: Cheng, Nan, et al.
Publicado: (2021)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function
por: Zhang, Wen, et al.
Publicado: (2022)

Astragaloside IV ameliorates allergic inflammation by inhibiting key initiating factors in the initial stage of sensitization
por: Bao, Kai-fan, et al.
Publicado: (2016)

Sacubitril Ameliorates Cardiac Fibrosis Through Inhibiting TRPM7 Channel
por: Jia, Tian, et al.
Publicado: (2021)

The Roles of lncRNA in Myocardial Infarction: Molecular Mechanisms, Diagnosis Biomarkers, and Therapeutic Perspectives
por: Xie, Luhan, et al.
Publicado: (2021)

Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity
por: Luo, Zhixiao, et al.
Publicado: (2021)

Therapeutic Effects of Astragaloside IV on Myocardial Injuries: Multi-Target Identification and Network Analysis
por: Zhao, Jing, et al.
Publicado: (2012)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB
por: QIU, LEI, et al.
Publicado: (2015)

The Role of Complement in Myocardial Infarction Reperfusion Injury: An Underappreciated Therapeutic Target
por: Vogel, Carl-Wilhelm
Publicado: (2020)

Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion
por: Wu, Xun, et al.
Publicado: (2021)

Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456
por: Wan, Jingjing, et al.
Publicado: (2023)

Inflammatory Cytokines Alter Mesenchymal Stem Cell Mechanosensing and Adhesion on Stiffened Infarct Heart Tissue After Myocardial Infarction
por: Zhu, Dan, et al.
Publicado: (2020)

TFEB Gene Promoter Variants Effect on Gene Expression in Acute Myocardial Infarction
por: Zhang, Jie, et al.
Publicado: (2021)

Ameliorating the Effect of Astragaloside IV on Learning and Memory Deficit after Chronic Cerebral Hypoperfusion in Rats
por: Kim, Sooyong, et al.
Publicado: (2015)

Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2021)

Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2022)

Therapeutic Potential of Exosomes Derived From circRNA_0002113 Lacking Mesenchymal Stem Cells in Myocardial Infarction
por: Tian, Tiantian, et al.
Publicado: (2022)

Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative stress by regulating the Nrf2/ARE signaling pathway
por: Wang, Jing, et al.
Publicado: (2019)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

Astragaloside IV Alleviates Ammonia-Induced Apoptosis and Oxidative Stress in Bovine Mammary Epithelial Cells
por: Wang, Fengge, et al.
Publicado: (2019)

Disruption of FGF Signaling Ameliorates Inflammatory Response in Hepatic Stellate Cells
por: Wang, Cong, et al.
Publicado: (2020)

IL-13 Derived Type 2 Innate Lymphocytes Ameliorates Cardiomyocyte Apoptosis Through STAT3 Signaling Pathway
por: Hong, Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mlq66hedl048kieumsksdfhr3k